Clovis investors lose faith as Rubraca struggles against Big Pharma's marketing giants

Clovis investors lose faith as Rubraca struggles against Big Pharma's marketing giants

Source: 
Fierce Pharma
snippet: 

It’s no secret that Clovis Oncology is up against some serious marketing muscle in the PARP inhibitor arena. And investors are doubting the company’s ability to hang in there.